The Arab Board for Clinical Research, a platform dedicated to advocating for the inclusion of diverse populations, with a focus on Arab Americans and Arabs in the Arab world, in clinical research studies. Our diversity initiative is led by Dr. Hadi Danawi, a Professor in Global Health and Epidemiology with a specific interest in clinical trial design and management, pharmacovigilance, and global health initiatives. Arab Board for Clinical Research is operating under an Assumed Name of "Doing Business As" of a limited liability incorporated in the state of Texas, USA.
Also, Arab Board for Clinical Research is affiliated with a 501 c(3) Not for profit organization with tax exempt status in the U.S with registered chapters in the Middle East.
Our mission at AB4CR is to create a more inclusive and fair research landscape by advocating for the inclusion of Arab ethnicities and other underrepresented populations in clinical research studies. We believe that increasing representation and diversity in research studies is crucial to improving the quality and safety of healthcare delivery for all individuals, regardless of their background or ethnicity.
Our vision at AB4CR is to promote awareness and engagement among clinical researchers, pharmaceutical companies, and the wider healthcare community about the importance of diversity in clinical research. We aim to bridge the gap between research institutions and underrepresented populations by addressing cultural and linguistic barriers, building trust and engagement, and promoting education and awareness about the benefits of clinical research participation.
At AB4CR, we are committed to creating positive social change in underserved communities by promoting participation of Arabs in clinical trials in the United States (U.S.), Africa and the Middle East. We achieve this by supplying technical help, curriculum development, and training of local associates for self-reliance in the best practices of clinical research while enforcing ICH-GCP guidelines and principles. Join Us